Using immunohistochemical staining and tissue microarrays, we assayed the expression of adipophilin in 61 patients with triple-negative breast cancer (TNBC) who underwent surgery from January 2006–December 2018. This evidence concerns the gene PLIN2 and triple-negative breast carcinoma.